Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David R. Holmes, M.D.
Mayo Clinic
Principal Investigator - Vivek Y. Reddy, M.D.
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mercy Gilbert Medical Center
Gilbert, Arizona, United States
- Arizona Heart Rhythm Research Center
Scottsdale, Arizona, United States
- Foundation for Cardiovascular Medicine
La Jolla, California, United States
- Scripps Green
La Jolla, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Orange County Heart
Orange, California, United States
- St. John'S Hospital / Pacific Heart
Santa Monica, California, United States
- Zasa Clinical Research
Atlantis, Florida, United States
- Baptist Hospital of Miami
Miami, Florida, United States
- Florida Hospital
Orlando, Florida, United States
- Emory University
Atlanta, Georgia, United States
- North Shore University
Evanston, Illinois, United States
- Iowa Heart Center
Des Moines, Iowa, United States
- Central Baptist Hospital
Lexington, Kentucky, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Lahey Clinic
Burlington, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- William Beaumont
Royal Oak, Michigan, United States
- Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Cardiology Associates of N. Mississippi
Tupelo, Mississippi, United States
- St. Luke'S Hospital
Kansas City, Missouri, United States
- St. John'S Mercy
St Louis, Missouri, United States
- Bryan Lgh
Lincoln, Nebraska, United States
- Englewood Hospital and Medical Center
Englewood, New Jersey, United States
- Columbia University Medical Center
New York, New York, United States
- Mt. Sinai School of Medicine
New York, New York, United States
- New York University Medical Center
New York, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Lindner Clinical Trial Center
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Moffitt Heart & Vascular
Wormleysburg, Pennsylvania, United States
- St. Thomas Research Institute
Nashville, Tennessee, United States
- Texas Cardiac Arrhythmia
Austin, Texas, United States
- Baylor Research Institute
Dallas, Texas, United States
- Methodist Hospital
Houston, Texas, United States
- Intermountain Medical Center
Salt Lake City, Utah, United States
- Fletcher Allen
Burlington, Vermont, United States
- Swedish Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2010
- Primary completion
- 31 Jan 2013
- Completion
- 30 Nov 2017
- Last update posted
- 26 Jul 2018
- Registered enrollment
- 407
- Registry id
- NCT01182441
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.